CSIMarket
 
Iradimed Corporation  (NASDAQ: IRMD)
 
Price: $83.4500 $-3.14 -3.626%
Day's High: $86.59030151367188 Week Perf: -3.39 %
Day's Low: $ 83.28 30 Day Perf: -8.51 %
Volume (M): 233,146 52 Wk High: $ 107.90
Volume (M$): $ 0 52 Wk Avg: $90.71
Open: $85.96 52 Wk Low: $67.84



 Market Capitalization (Millions $) 1,074
 Shares Outstanding (Millions) 13
 Employees 166
 Revenues (TTM) (Millions $) 86
 Net Income (TTM) (Millions $) 23
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 3

Business Description


Iradimed Corporation is a medical technology company that specializes in the development and manufacturing of MRI-compatible intravenous (IV) infusion pumps and other related products. The company was founded in 1992 and is based in Winter Springs, Florida.

Iradimed's flagship product is the MRidium MRI-compatible IV infusion pump system, which is designed to safely deliver medication and fluids to patients undergoing magnetic resonance imaging (MRI) procedures. The MRidium pump system is unique in that it is specifically engineered to be used in the MRI environment, where traditional infusion pumps are not safe or suitable due to the strong magnetic fields and radio frequency interference.

The company also offers a range of associated products and accessories, including IV sets, administration sets, and tubing, all designed for use in the MRI environment. These products are primarily sold to hospitals and other healthcare facilities.

Iradimed Corporation has established a strong presence in the medical technology industry, with its products being used in leading hospitals worldwide. Their MRI-compatible IV infusion pump system is highly regarded for its safety, durability, and ease of use. The company continues to innovate and develop new products to meet the evolving needs of the healthcare industry.


   Company Address: 12705 Ingenuity Drive Orlando 32826 FL
   Company Phone Number: 677-8022   Stock Exchange / Ticker: NASDAQ IRMD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Product Service News

IRADIMED Corporation Reports 23.1% Revenue Growth as It Prepares for 2025 Wells Fargo Healthcare Conference.,

Published Wed, Aug 27 2025 9:01 AM UTC

IRADIMED Corporation to Showcase Growth and Innovation at the 2025 Wells Fargo Healthcare Conference Orlando, Fla., Aug. 26, 2025 IRADIMED CORPORATION (NASDAQ: IRMD), a global leader in the development of groundbreaking medical devices specifically engineered for Magnetic Resonance Imaging (MRI) environments, proudly announces its participation in the Wells Fargo 2025 Heal...

Dividend

Dividend Declaration and Resilient Growth: Iradimed Corporation's Strategic Positioning in MRI Innovations

Published Thu, Aug 1 2024 1:29 PM UTC

Iradimed Corporation: Navigating Growth and Dividend Stability Amidst a Competitive Landscape
In a pivotal announcement on August 1, 2024, Iradimed Corporation (NASDAQ: IRMD) reported its financial results for the second quarter of 2024, highlighting its prowess in the innovative medical devices sector, particularly within magnetic resonance imaging (MRI). The firm, reno...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 46.71
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 12.44
Price to Sales (Expected) -
Price to Book 10.56
PEG (TTM) 4.53

Financial Strength Current
Quick Ratio 6.45
Working Capital Ratio 9.22
Leverage Ratio (MRQ) 0.13
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 1.79 $
Revenues (TTM) 6.71 $
Cash Flow (TTM) 0.26 $
Cash 4.59 $
Book Value 7.9 $
Dividend (TTM) 1.2 $

Efficiency Current
Revenue per Employee (TTM) 520,114
Net Income per Employee (TTM) 138,883
Receivable Turnover Ratio (TTM) 6.38
Inventory Turnover Ratio (TTM) 1.76
Asset Turnover Ratio (TTM) 0.76

Profitability Ratios Current
Gross Margin (MRQ) 74.07 %
Operating Margin (MRQ) 31.23 %
Net Margin (MRQ) 25.5 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 22.49 %

Management Effectiveness Current
Return On Assets (TTM) 20.26 %
Return On Investment (TTM) 22.57 %
Return On Equity (TTM) 23.45 %
Dividend Yield 1.24 %
Pay out Ratio (TTM) 67.17 %



Iradimed's Segments
United States    169.77 % of total Revenue
MRI Compatible Intravenous IV Infusion Pump Systems    37.62 % of total Revenue
MRI Compatible IV Infusion Pumps    68.86 % of total Revenue
MRI Compatible Patient Vital Signs Monitoring Systems    67.29 % of total Revenue
Services and other    6.92 % of total Revenue
Device Revenue    142.88 % of total Revenue
Disposable Revenue    47.29 % of total Revenue
Service    10.3 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.